Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2014
08/12/2014US8802097 Anti-RSPO1 antibodies
08/12/2014US8802096 Anti-C5a binding antibodies with high block activity
08/12/2014US8802093 HER2/neu-specific antibodies and methods of using same
08/12/2014US8802092 Mesothelioma therapeutic agent
08/12/2014US8802088 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan
08/12/2014US8801955 Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preparation thereof
08/12/2014US8800906 Use of transforming growth factor-beta neutralizing antibodies and fusion proteins thereof in treating pain
08/12/2014CA2776927C Phosphorylcholine conjugates and corresponding antibodies
08/12/2014CA2774441C Antibodies immunoreactive with mutant hydroxypenylpyruvate dioxygenase
08/12/2014CA2607663C Compositions and methods for increasing the stability of antibodies
08/12/2014CA2569561C Rabbit monoclonal antibodies to hepatitis b surface antigens and methods of using the same
08/12/2014CA2569509C Anti-cd3 antibodies and methods of use thereof
08/12/2014CA2558685C Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
08/12/2014CA2551813C Compositions and methods for the treatment of tumor of hematopoietic origin
08/12/2014CA2367989C Diagnosis of whipple disease
08/07/2014WO2014121221A1 Administration of an anti-activin-a compound to a subject
08/07/2014WO2014121087A1 Antibodies comprising chimeric constant domains
08/07/2014WO2014121053A1 Methods for increasing immunoglobulin a levels
08/07/2014WO2014121045A1 Colostrum composition enriched in anti-endotoxin antibodies
08/07/2014WO2014120975A1 Antibody-mediated immunocontraception
08/07/2014WO2014120916A1 Pegylated domain antibodies monovalent for cd28 binding and methods of use
08/07/2014WO2014120891A2 Fibronectin based scaffold proteins
08/07/2014WO2014120619A2 Compositions and methods of use in treating metabolic disorders
08/07/2014WO2014118705A1 Methods of treating chronic kidney disease-mineral and bone disorder using sclerostin antagonists
08/07/2014WO2014118552A1 Inhibition of the complement system
08/07/2014WO2014117220A1 Anti-cd83 antibodies and use thereof
08/07/2014WO2014049581A3 Monoclonal antibodies against npm1 and acetylated npm1, methods and kit thereof
08/07/2014WO2014020129A3 Allatostatin-b peptides for inducing the settlement of lophotrochozoan marine larvae
08/07/2014WO2013119716A8 Compositions and methods for using csf1r inhibitors
08/07/2014US20140223591 Antibody-mediated immunocontraception
08/07/2014US20140223588 A2m fragments and applications thereof
08/07/2014US20140221636 Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof
08/07/2014US20140221626 Compositions and methods for detection of methadone metabolite
08/07/2014US20140221625 B cell lineage based immunogen design with humanized animals
08/07/2014US20140221624 Humanization of rabbit antibodies using a universal antibody framework
08/07/2014US20140221623 Interleukin-6 receptor binding polypeptides
08/07/2014US20140221622 Monovalent binding proteins
08/07/2014US20140221621 Single-chain multivalent binding protein compositions and methods
08/07/2014US20140221620 Anti-human p-cadherin (cdh3) recombinant antibody
08/07/2014US20140221619 Methods and Compositions for Increasing Protein Production
08/07/2014US20140221607 Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
08/07/2014US20140221250 Rationally Designed, Synthetic Antibody Libraries and Uses Therefor
08/07/2014US20140220678 Methods and compositions relating to improved lentiviral vectors and their applications
08/07/2014US20140220634 Antibodies binding human collagen II
08/07/2014US20140220047 Monomethylvaline compounds capable of conjugation to ligands
08/07/2014US20140220043 Gene signature for predicting prognosis of patients with solid tumors
08/07/2014US20140220042 Anti-c (epsilon)mx antibodies capable of binding to human mige on b lymphocytes
08/07/2014US20140220041 Compounds for use in the treatment of alzheimer's disease
08/07/2014US20140220040 Antibodies to lrp6
08/07/2014US20140220039 ApoIII and the Treatment and Diagnosis of Diabetes
08/07/2014US20140220038 Lrp1 as key receptor for the transfer of sterified cholesterol from very-low-density lipoproteins (vldl) to ischaemic cardiac muscle
08/07/2014US20140220037 Methods for treating reperfusion injuries
08/07/2014US20140220034 Serpinf2-Binding Molecules and Method of Use Thereof
08/07/2014US20140220033 Administration of an Anti-Activin-A Compound to a Subject
08/07/2014US20140220032 Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
08/07/2014US20140220031 Anti-cd154 antibodies
08/07/2014US20140220030 Use of cgrp antagonist compounds for treatment of psoriasis
08/07/2014US20140220028 Antibodies directed against signal peptides, methods and uses thereof
08/07/2014US20140220027 1d05 pcsk9 antagonists
08/07/2014US20140220026 Therapeutic use of specific ligand in msrv associated diseases
08/07/2014US20140220025 Novel stip1 polypeptides and uses thereof
08/07/2014US20140220024 Chymase compositions, antibodies, diagnostics, and therapeutic methods related thereto
08/07/2014US20140220023 Method of treating osteoarthritis with an antibody to ngf
08/07/2014US20140220022 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
08/07/2014US20140220021 Therapeutic agent for autoimmune diseases comprising pd-1 agonist
08/07/2014US20140220020 Il-1 binding proteins
08/07/2014US20140220019 Dual variable domain immunoglobulins and uses thereof
08/07/2014US20140220016 Antibody- endostatin fusion protein and its variants
08/07/2014US20140220014 Levels of bcma protein expression on b cells and use in diagnostic methods
08/07/2014US20140220013 Method for the diagnosis and prognosis of malignant diseases
08/07/2014US20140220012 Novel VISTA-Ig constructs and the use of VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders
08/07/2014US20140220010 Variants of humanized immunomodulatory monoclonal antibodies
08/07/2014US20140220009 Compositions and Methods for Treating Cocaine-Related Disorders
08/07/2014US20140220008 Humanized Anti-CD4 Antibody With Immunosuppressive Properties
08/07/2014US20140220005 N-Cadherin: Target for Cancer Diagnosis and Therapy
08/07/2014US20140220004 Compositions and methods for treating pain
08/07/2014US20140220003 Therapeutic method for mesothelioma
08/07/2014US20140220001 Methods and Monitoring of Treatment with a DLL4 Antagonist
08/07/2014US20140219999 Treatment of colon cancer using complement inhibitors
08/07/2014US20140219978 Gp100-specific t cell receptors and related materials and methods of use
08/07/2014US20140219956 Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
08/07/2014US20140219955 Fusion molecules and il-15 variants
08/07/2014US20140219919 Il-11r binding proteins and uses thereof
08/07/2014US20140219913 Dual Specific Binding Proteins Having a Receptor Sequence
08/07/2014US20140219912 Dual variable domain immunoglobulins and uses thereof
08/07/2014DE102010039019B4 Antikörper gegen 6-sulfo LacNAc positive humane dendritische Zellen und deren Verwendung Antibodies against 6-sulfo LacNAc positive human dendritic cells and their use
08/06/2014EP2762564A1 Ion concentration-dependent binding molecule library
08/06/2014EP2762497A1 Bispecific antibodies against CD3epsilon and BCMA
08/06/2014EP2762496A1 Method for the selection of antibodies against BCMA
08/06/2014EP2762495A1 Antibodies to TNF alpha
08/06/2014EP2762494A2 Monoclonal antibodies against scrapie prion protein (PrPSc), and the use thereof
08/06/2014EP2762493A1 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
08/06/2014EP2762492A2 A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
08/06/2014EP2762491A2 Binding molecule having influenza a virus-neutralizing activity produced from human b cell
08/06/2014EP2762490A1 Process for obtaining immunoglobulins from colostrum
08/06/2014EP2761008A1 Chimaeric surrogate light chains (slc) comprising human vpreb
08/06/2014EP2760893A2 Anti-erbb3 antibodies and uses thereof
08/06/2014EP2760892A1 Multi-specific binding molecules targeting aberrant cells
08/06/2014EP2760891A1 Hybrid constant regions
08/06/2014EP2760890A2 THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 1494